{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:12:32Z","timestamp":1788444752875,"version":"build-2803163510"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"crossref","award":["1-19-ICTS-129"],"award-info":[{"award-number":["1-19-ICTS-129"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000901","name":"Juvenile Diabetes Research Foundation International","doi-asserted-by":"crossref","award":["3-SRA-2018-478-S-B"],"award-info":[{"award-number":["3-SRA-2018-478-S-B"]}],"id":[{"id":"10.13039\/100000901","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01 DK 121528"],"award-info":[{"award-number":["R01 DK 121528"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01 DK 125014"],"award-info":[{"award-number":["R01 DK 125014"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00125-026-06794-3","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T22:46:46Z","timestamp":1783723606000},"page":"2862-2881","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Age-independent immune subtypes in type 1 diabetes exhibit distinct post-onset progression rates and immunotherapeutic responses"],"prefix":"10.1007","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6173-1291","authenticated-orcid":false,"given":"Amina","family":"Bedrat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6604-8459","authenticated-orcid":false,"given":"Nathan A.","family":"Truchan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2862-3923","authenticated-orcid":false,"given":"Tarun","family":"Pant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark F.","family":"Roethle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9616-8841","authenticated-orcid":false,"given":"Yi-Guang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4023-7339","authenticated-orcid":false,"given":"Chien-Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9941-0314","authenticated-orcid":false,"given":"Martin J.","family":"Hessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"issue":"20","key":"6794_CR1","doi-asserted-by":"publisher","first-page":"eadn2136","DOI":"10.1126\/sciadv.adn2136","volume":"10","author":"T Pant","year":"2024","unstructured":"Pant T, Lin CW, Bedrat A et al (2024) Monocytes in type 1 diabetes families exhibit high cytolytic activity and subset abundances that correlate with clinical progression. Sci Adv 10(20):eadn2136. https:\/\/doi.org\/10.1126\/sciadv.adn2136","journal-title":"Sci Adv"},{"issue":"4","key":"6794_CR2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrendo.2009.21","volume":"5","author":"DL Eizirik","year":"2009","unstructured":"Eizirik DL, Colli ML, Ortis F (2009) The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol 5(4):219\u2013226.\u00a0https:\/\/doi.org\/10.1038\/nrendo.2009.21","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"6794_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2337\/dc19-0880","volume":"43","author":"M Battaglia","year":"2020","unstructured":"Battaglia M, Ahmed S, Anderson MS et al (2020) Introducing the endotype concept to address the challenge of disease heterogeneity in type 1 diabetes. Diabetes Care 43(1):5\u201312. https:\/\/doi.org\/10.2337\/dc19-0880","journal-title":"Diabetes Care"},{"issue":"9","key":"6794_CR4","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41574-023-00853-0","volume":"19","author":"MJ Redondo","year":"2023","unstructured":"Redondo MJ, Morgan NG (2023) Heterogeneity and endotypes in type 1 diabetes mellitus. Nat Rev Endocrinol 19(9):542\u2013554. https:\/\/doi.org\/10.1038\/s41574-023-00853-0","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"6794_CR5","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1111\/dme.14314","volume":"37","author":"A Casu","year":"2020","unstructured":"Casu A, Kanapka LG, Foster NC et al (2020) Characteristics of adult- compared to childhood-onset type 1 diabetes. Diabet Med 37(12):2109\u20132115. https:\/\/doi.org\/10.1111\/dme.14314","journal-title":"Diabet Med"},{"issue":"6","key":"6794_CR6","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1007\/s00125-020-05115-6","volume":"63","author":"P Leete","year":"2020","unstructured":"Leete P, Oram RA, McDonald TJ et al (2020) Studies of insulin and proinsulin in pancreas and serum support the existence of aetiopathological endotypes of type 1 diabetes associated with age at diagnosis. Diabetologia 63(6):1258\u20131267. https:\/\/doi.org\/10.1007\/s00125-020-05115-6","journal-title":"Diabetologia"},{"issue":"11","key":"6794_CR7","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.2337\/db14-0365","volume":"63","author":"S Arif","year":"2014","unstructured":"Arif S, Leete P, Nguyen V et al (2014) Blood and islet phenotypes indicate immunological heterogeneity in type 1 diabetes. Diabetes 63(11):3835\u20133845. https:\/\/doi.org\/10.2337\/db14-0365","journal-title":"Diabetes"},{"issue":"11","key":"6794_CR8","doi-asserted-by":"publisher","first-page":"3960","DOI":"10.2337\/db14-0214","volume":"63","author":"YG Chen","year":"2014","unstructured":"Chen YG, Cabrera SM, Jia S et al (2014) Molecular signatures differentiate immune States in type 1 diabetic families. Diabetes 63(11):3960\u20133973. https:\/\/doi.org\/10.2337\/db14-0214","journal-title":"Diabetes"},{"issue":"11","key":"6794_CR9","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1007\/s00125-018-4708-x","volume":"61","author":"SM Cabrera","year":"2018","unstructured":"Cabrera SM, Engle S, Kaldunski M et al (2018) Innate immune activity as a predictor of persistent insulin secretion and association with responsiveness to CTLA4-Ig treatment in recent-onset type 1 diabetes. Diabetologia 61(11):2356\u20132370. https:\/\/doi.org\/10.1007\/s00125-018-4708-x","journal-title":"Diabetologia"},{"issue":"4","key":"6794_CR10","doi-asserted-by":"publisher","first-page":"312","DOI":"10.4161\/isl.21510","volume":"4","author":"AM Jackson","year":"2012","unstructured":"Jackson AM, Kanak MA, Grishman EK, Chaussabel D, Levy MF, Naziruddin B (2012) Gene expression changes in human islets exposed to type 1 diabetic serum. Islets 4(4):312\u2013319. https:\/\/doi.org\/10.4161\/isl.21510","journal-title":"Islets"},{"key":"6794_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1479-5876-12-65","volume":"12","author":"P Khaenam","year":"2014","unstructured":"Khaenam P, Rinchai D, Altman MC et al (2014) A transcriptomic reporter assay employing neutrophils to measure immunogenic activity of septic patients\u2019 plasma. J Transl Med 12:65. https:\/\/doi.org\/10.1186\/1479-5876-12-65","journal-title":"J Transl Med"},{"issue":"23","key":"6794_CR12","doi-asserted-by":"publisher","first-page":"e126917","DOI":"10.1172\/jci.insight.126917","volume":"4","author":"C Speake","year":"2019","unstructured":"Speake C, Skinner SO, Berel D et al (2019) A composite immune signature parallels disease progression across T1D subjects. JCI Insight 4(23):e126917. https:\/\/doi.org\/10.1172\/jci.insight.126917","journal-title":"JCI Insight"},{"issue":"4","key":"6794_CR13","doi-asserted-by":"publisher","first-page":"826","DOI":"10.2337\/dc09-1349","volume":"33","author":"PA Gottlieb","year":"2010","unstructured":"Gottlieb PA, Quinlan S, Krause-Steinrauf H et al (2010) Failure to preserve beta-cell function with mycophenolate mofetil and daclizumab combined therapy in patients with new- onset type 1 diabetes. Diabetes Care 33(4):826\u2013832. https:\/\/doi.org\/10.2337\/dc09-1349","journal-title":"Diabetes Care"},{"issue":"22","key":"6794_CR14","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1056\/NEJMoa0904452","volume":"361","author":"MD Pescovitz","year":"2009","unstructured":"Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H et al (2009) Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med 361(22):2143\u20132152. https:\/\/doi.org\/10.1056\/NEJMoa0904452","journal-title":"N Engl J Med"},{"issue":"9788","key":"6794_CR15","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0140-6736(11)60895-7","volume":"378","author":"DK Wherrett","year":"2011","unstructured":"Wherrett DK, Bundy B, Becker DJ et al (2011) Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial. Lancet 378(9788):319\u2013327. https:\/\/doi.org\/10.1016\/S0140-6736(11)60895-7","journal-title":"Lancet"},{"issue":"9789","key":"6794_CR16","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S0140-6736(11)60886-6","volume":"378","author":"T Orban","year":"2011","unstructured":"Orban T, Bundy B, Becker DJ et al (2011) Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial. Lancet 378(9789):412\u2013419. https:\/\/doi.org\/10.1016\/S0140-6736(11)60886-6","journal-title":"Lancet"},{"issue":"9881","key":"6794_CR17","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/S0140-6736(13)60023-9","volume":"381","author":"A Moran","year":"2013","unstructured":"Moran A, Bundy B, Becker DJ et al (2013) Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials. Lancet 381(9881):1905\u20131915. https:\/\/doi.org\/10.1016\/S0140-6736(13)60023-9","journal-title":"Lancet"},{"issue":"9","key":"6794_CR18","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.2337\/dc18-0494","volume":"41","author":"MJ Haller","year":"2018","unstructured":"Haller MJ, Schatz DA, Skyler JS et al (2018) Low-dose Anti-Thymocyte Globulin (ATG) preserves beta-cell function and improves HbA1c in new-onset type 1 diabetes. Diabetes Care 41(9):1917\u20131925. https:\/\/doi.org\/10.2337\/dc18-0494","journal-title":"Diabetes Care"},{"issue":"1","key":"6794_CR19","doi-asserted-by":"publisher","first-page":"250","DOI":"10.2337\/diabetes.53.1.250","volume":"53","author":"JP Palmer","year":"2004","unstructured":"Palmer JP, Fleming GA, Greenbaum CJ et al (2004) C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21\u201322 October 2001. Diabetes 53(1):250\u2013264. https:\/\/doi.org\/10.2337\/diabetes.53.1.250","journal-title":"Diabetes"},{"key":"6794_CR20","doi-asserted-by":"publisher","unstructured":"Gentleman RC, Carey VJ, Bates DM et al (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5(10): R80.\u00a0https:\/\/doi.org\/10.1186\/gb-2004-5-10-r80","DOI":"10.1186\/gb-2004-5-10-r80"},{"issue":"1","key":"6794_CR21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W da Huang","year":"2009","unstructured":"da Huang W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4(1):44\u201357. https:\/\/doi.org\/10.1038\/nprot.2008.211","journal-title":"Nat Protoc"},{"issue":"1","key":"6794_CR22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/bioinformatics\/18.1.207","volume":"18","author":"A Sturn","year":"2002","unstructured":"Sturn A, Quackenbush J, Trajanoski Z (2002) Genesis: cluster analysis of microarray data. Bioinformatics 18(1):207\u2013208. https:\/\/doi.org\/10.1093\/bioinformatics\/18.1.207","journal-title":"Bioinformatics"},{"issue":"483","key":"6794_CR23","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1198\/016214508000000454","volume":"103","author":"Y Liu","year":"2008","unstructured":"Liu Y, Hayes D, Nobel A, Marron JS (2008) Statistical significance of clustering for high-dimension, low-sample size data. J Am Stat Assoc 103(483):1281\u20131293. https:\/\/doi.org\/10.1198\/016214508000000454","journal-title":"J Am Stat Assoc"},{"issue":"2","key":"6794_CR24","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/s1570-0232(02)00827-9","volume":"784","author":"NM Moreau","year":"2003","unstructured":"Moreau NM, Goupry SM, Antignac JP et al (2003) Simultaneous measurement of plasma concentrations and 13C-enrichment of short-chain fatty acids, lactic acid and ketone bodies by gas chromatography coupled to mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 784(2):395\u2013403. https:\/\/doi.org\/10.1016\/s1570-0232(02)00827-9","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"9","key":"6794_CR25","doi-asserted-by":"publisher","first-page":"e24145","DOI":"10.1371\/journal.pone.0024145","volume":"6","author":"MB Kirschner","year":"2011","unstructured":"Kirschner MB, Kao SC, Edelman JJ et al (2011) Haemolysis during sample preparation alters microRNA content of plasma. PLoS One 6(9):e24145. https:\/\/doi.org\/10.1371\/journal.pone.0024145","journal-title":"PLoS One"},{"issue":"9","key":"6794_CR26","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29(9):e45. https:\/\/doi.org\/10.1093\/nar\/29.9.e45","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"6794_CR27","doi-asserted-by":"publisher","first-page":"D142","DOI":"10.1093\/nar\/gkz1022","volume":"48","author":"T Kehl","year":"2020","unstructured":"Kehl T, Kern F, Backes C et al (2020) miRPathDB 2.0: a novel release of the miRNA pathway dictionary database. Nucleic Acids Res 48(D1):D142\u2013D147. https:\/\/doi.org\/10.1093\/nar\/gkz1022","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"6794_CR28","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.2337\/dc08-1987","volume":"32","author":"HB Mortensen","year":"2009","unstructured":"Mortensen HB, Hougaard P, Swift P et al (2009) New definition for the partial remission period in children and adolescents with type 1 diabetes. Diabetes Care 32(8):1384\u20131390. https:\/\/doi.org\/10.2337\/dc08-1987","journal-title":"Diabetes Care"},{"issue":"8","key":"6794_CR29","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.2337\/db11-1538","volume":"61","author":"CJ Greenbaum","year":"2012","unstructured":"Greenbaum CJ, Beam CA, Boulware D et al (2012) Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data. Diabetes 61(8):2066\u20132073. https:\/\/doi.org\/10.2337\/db11-1538","journal-title":"Diabetes"},{"issue":"10","key":"6794_CR30","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.2337\/db14-0047","volume":"63","author":"T Orban","year":"2014","unstructured":"Orban T, Beam CA, Xu P et al (2014) Reduction in CD4 central memory T-cell subset in costimulation modulator abatacept-treated patients with recent-onset type 1 diabetes is associated with slower C-peptide decline. Diabetes 63(10):3449\u20133457. https:\/\/doi.org\/10.2337\/db14-0047","journal-title":"Diabetes"},{"key":"6794_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-0318-1","volume-title":"Mixed-effects models in S and Splus","author":"JC Pinheiro","year":"2000","unstructured":"Pinheiro JC, Bates DM (2000) Mixed-effects models in S and Splus. Springer-Verlag, New York"},{"issue":"2","key":"6794_CR32","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/bioinformatics\/btu622","volume":"31","author":"B Afsari","year":"2015","unstructured":"Afsari B, Fertig EJ, Geman D, Marchionni L (2015) switchBox: an R package for k-Top Scoring Pairs classifier development. Bioinformatics 31(2):273\u2013274. https:\/\/doi.org\/10.1093\/bioinformatics\/btu622","journal-title":"Bioinformatics"},{"issue":"3","key":"6794_CR33","doi-asserted-by":"publisher","first-page":"476","DOI":"10.2337\/dc14-1952","volume":"38","author":"AK Davis","year":"2015","unstructured":"Davis AK, DuBose SN, Haller MJ et al (2015) Prevalence of detectable C-Peptide according to age at diagnosis and duration of type 1 diabetes. Diabetes Care 38(3):476\u2013481. https:\/\/doi.org\/10.2337\/dc14-1952","journal-title":"Diabetes Care"},{"key":"6794_CR34","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3389\/fimmu.2016.00406","volume":"7","author":"Z Qin","year":"2016","unstructured":"Qin Z, Wang PY, Su DF, Liu X (2016) miRNA-124 in immune system and immune disorders. Front Immunol 7:406. https:\/\/doi.org\/10.3389\/fimmu.2016.00406","journal-title":"Front Immunol"},{"issue":"12","key":"6794_CR35","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s00011-022-01643-6","volume":"71","author":"WD Xu","year":"2022","unstructured":"Xu WD, Feng SY, Huang AF (2022) Role of miR-155 in inflammatory autoimmune diseases: a comprehensive review. Inflamm Res 71(12):1501\u20131517. https:\/\/doi.org\/10.1007\/s00011-022-01643-6","journal-title":"Inflamm Res"},{"issue":"6","key":"6794_CR36","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.immuni.2014.03.014","volume":"40","author":"TM Escobar","year":"2014","unstructured":"Escobar TM, Kanellopoulou C, Kugler DG et al (2014) miR-155 activates cytokine gene expression in Th17 cells by regulating the DNA-binding protein Jarid2 to relieve polycomb-mediated repression. Immunity 40(6):865\u2013879. https:\/\/doi.org\/10.1016\/j.immuni.2014.03.014","journal-title":"Immunity"},{"issue":"8","key":"6794_CR37","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41577-024-01014-8","volume":"24","author":"ER Mann","year":"2024","unstructured":"Mann ER, Lam YK, Uhlig HH (2024) Short-chain fatty acids: linking diet, the microbiome and immunity. Nat Rev Immunol 24(8):577\u2013595. https:\/\/doi.org\/10.1038\/s41577-024-01014-8","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"6794_CR38","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.4049\/jimmunol.1901439","volume":"204","author":"M Eichmann","year":"2020","unstructured":"Eichmann M, Baptista R, Ellis RJ, Heck S, Peakman M, Beam CA (2020) Costimulation blockade disrupts CD4+ T cell memory pathways and uncouples their link to decline in beta-cell function in type 1 diabetes. J Immunol 204(12):3129\u20133138. https:\/\/doi.org\/10.4049\/jimmunol.1901439","journal-title":"J Immunol"},{"issue":"11","key":"6794_CR39","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s11892-018-1083-4","volume":"18","author":"P Leete","year":"2018","unstructured":"Leete P, Mallone R, Richardson SJ, Sosenko JM, Redondo MJ, Evans-Molina C (2018) The effect of age on the progression and severity of type 1 diabetes: potential effects on disease mechanisms. Curr Diab Rep 18(11):115. https:\/\/doi.org\/10.1007\/s11892-018-1083-4","journal-title":"Curr Diab Rep"},{"issue":"9","key":"6794_CR40","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.2337\/dc18-0087","volume":"41","author":"MJ Redondo","year":"2018","unstructured":"Redondo MJ, Geyer S, Steck AK et al (2018) A type 1 diabetes genetic risk score predicts progression of islet autoimmunity and development of type 1 diabetes in individuals at risk. Diabetes Care 41(9):1887\u20131894. https:\/\/doi.org\/10.2337\/dc18-0087","journal-title":"Diabetes Care"},{"issue":"9","key":"6794_CR41","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.2337\/dc17-0238","volume":"40","author":"JP Krischer","year":"2017","unstructured":"Krischer JP, Lynch KF, Lernmark A et al (2017) Genetic and environmental interactions modify the risk of diabetes-related autoimmunity by 6 years of age: the TEDDY Study. Diabetes Care 40(9):1194\u20131202. https:\/\/doi.org\/10.2337\/dc17-0238","journal-title":"Diabetes Care"},{"issue":"8","key":"6794_CR42","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1007\/s00125-012-2571-8","volume":"55","author":"CC Patterson","year":"2012","unstructured":"Patterson CC, Gyurus E, Rosenbauer J et al (2012) Trends in childhood type 1 diabetes incidence in Europe during 1989\u20132008: evidence of non-uniformity over time in rates of increase. Diabetologia 55(8):2142\u20132147. https:\/\/doi.org\/10.1007\/s00125-012-2571-8","journal-title":"Diabetologia"},{"issue":"1","key":"6794_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/dmrr.1141","volume":"27","author":"K Vehik","year":"2011","unstructured":"Vehik K, Dabelea D (2011) The changing epidemiology of type 1 diabetes: why is it going through the roof? Diabetes Metab Res Rev 27(1):3\u201313. https:\/\/doi.org\/10.1002\/dmrr.1141","journal-title":"Diabetes Metab Res Rev"},{"issue":"2","key":"6794_CR44","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2337\/dbi20-0026","volume":"70","author":"A Petrelli","year":"2021","unstructured":"Petrelli A, Atkinson MA, Pietropaolo M, Giannoukakis N (2021) Modulation of leukocytes of the innate arm of the immune system as a potential approach to prevent the onset and progression of type 1 diabetes. Diabetes 70(2):313\u2013322. https:\/\/doi.org\/10.2337\/dbi20-0026","journal-title":"Diabetes"},{"issue":"1","key":"6794_CR45","doi-asserted-by":"publisher","first-page":"34","DOI":"10.20945\/2359-3997000000006","volume":"62","author":"DF Garcia-Diaz","year":"2018","unstructured":"Garcia-Diaz DF, Pizarro C, Camacho-Guillen P, Codner E, Soto N, Perez-Bravo F (2018) Expression of miR-155, miR-146a, and miR-326 in T1D patients from Chile: relationship with autoimmunity and inflammatory markers. Arch Endocrinol Metab 62(1):34\u201340. https:\/\/doi.org\/10.20945\/2359-3997000000006","journal-title":"Arch Endocrinol Metab"},{"key":"6794_CR46","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.diabres.2018.03.044","volume":"141","author":"TS Assmann","year":"2018","unstructured":"Assmann TS, Recamonde-Mendoza M, Punales M, Tschiedel B, Canani LH, Crispim D (2018) MicroRNA expression profile in plasma from type 1 diabetic patients: Case-control study and bioinformatic analysis. Diabetes Res Clin Pract 141:35\u201346. https:\/\/doi.org\/10.1016\/j.diabres.2018.03.044","journal-title":"Diabetes Res Clin Pract"},{"issue":"10","key":"6794_CR47","doi-asserted-by":"publisher","first-page":"6226","DOI":"10.4049\/jimmunol.1000491","volume":"185","author":"P Wang","year":"2010","unstructured":"Wang P, Hou J, Lin L et al (2010) Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1. J Immunol 185(10):6226\u20136233. https:\/\/doi.org\/10.4049\/jimmunol.1000491","journal-title":"J Immunol"},{"issue":"2","key":"6794_CR48","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.immuni.2009.06.024","volume":"31","author":"A Androulidaki","year":"2009","unstructured":"Androulidaki A, Iliopoulos D, Arranz A et al (2009) The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity 31(2):220\u2013231. https:\/\/doi.org\/10.1016\/j.immuni.2009.06.024","journal-title":"Immunity"},{"issue":"17","key":"6794_CR49","doi-asserted-by":"publisher","first-page":"7113","DOI":"10.1073\/pnas.0902636106","volume":"106","author":"RM O'Connell","year":"2009","unstructured":"O\u2019Connell RM, Chaudhuri AA, Rao DS, Baltimore D (2009) Inositol phosphatase SHIP1 is a primary target of miR-155. Proc Natl Acad Sci U S A 106(17):7113\u20137118. https:\/\/doi.org\/10.1073\/pnas.0902636106","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"6794_CR50","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/imm.13477","volume":"166","author":"HJ Kim","year":"2022","unstructured":"Kim HJ, Park SO, Byeon HW et al (2022) T cell-intrinsic miR-155 is required for Th2 and Th17-biased responses in acute and chronic airway inflammation by targeting several different transcription factors. Immunology 166(3):357\u2013379. https:\/\/doi.org\/10.1111\/imm.13477","journal-title":"Immunology"},{"key":"6794_CR51","doi-asserted-by":"publisher","first-page":"1320305","DOI":"10.3389\/fimmu.2023.1320305","volume":"14","author":"SJ Xu","year":"2023","unstructured":"Xu SJ, Chen JH, Chang S, Li HL (2023) The role of miRNAs in T helper cell development, activation, fate decisions and tumor immunity. Front Immunol 14:1320305. https:\/\/doi.org\/10.3389\/fimmu.2023.1320305","journal-title":"Front Immunol"},{"issue":"9","key":"6794_CR52","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1084\/jem.20160204","volume":"213","author":"WH Liu","year":"2016","unstructured":"Liu WH, Kang SG, Huang Z et al (2016) A miR-155-Peli1-c-Rel pathway controls the generation and function of T follicular helper cells. J Exp Med 213(9):1901\u20131919. https:\/\/doi.org\/10.1084\/jem.20160204","journal-title":"J Exp Med"},{"issue":"5","key":"6794_CR53","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00592-016-0961-y","volume":"54","author":"TS Assmann","year":"2017","unstructured":"Assmann TS, Duarte GCK, Brondani LA et al (2017) Polymorphisms in genes encoding miR-155 and miR-146a are associated with protection to type 1 diabetes mellitus. Acta Diabetol 54(5):433\u2013441. https:\/\/doi.org\/10.1007\/s00592-016-0961-y","journal-title":"Acta Diabetol"},{"issue":"1","key":"6794_CR54","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/glia.23530","volume":"67","author":"X Liu","year":"2019","unstructured":"Liu X, Zhou F, Yang Y et al (2019) MiR-409-3p and MiR-1896 co-operatively participate in IL-17-induced inflammatory cytokine production in astrocytes and pathogenesis of EAE mice via targeting SOCS3\/STAT3 signaling. Glia 67(1):101\u2013112. https:\/\/doi.org\/10.1002\/glia.23530","journal-title":"Glia"},{"issue":"6","key":"6794_CR55","doi-asserted-by":"publisher","first-page":"101591","DOI":"10.1016\/j.xcrm.2024.101591","volume":"5","author":"G Sebastiani","year":"2024","unstructured":"Sebastiani G, Grieco GE, Bruttini M et al (2024) A set of circulating microRNAs belonging to the 14q32 chromosome locus identifies two subgroups of individuals with recent-onset type 1 diabetes. Cell Rep Med 5(6):101591. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101591","journal-title":"Cell Rep Med"},{"issue":"5 Pt 1","key":"6794_CR56","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/j.1600-6143.2006.01288.x","volume":"6","author":"MD Pescovitz","year":"2006","unstructured":"Pescovitz MD (2006) Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action. Am J Transplant 6(5 Pt 1):859\u2013866. https:\/\/doi.org\/10.1111\/j.1600-6143.2006.01288.x","journal-title":"Am J Transplant"},{"issue":"4","key":"6794_CR57","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.4049\/jimmunol.178.4.2287","volume":"178","author":"AJ Stel","year":"2007","unstructured":"Stel AJ, Ten Cate B, Jacobs S et al (2007) Fas receptor clustering and involvement of the death receptor pathway in rituximab-mediated apoptosis with concomitant sensitization of lymphoma B cells to fas-induced apoptosis. J Immunol 178(4):2287\u20132295. https:\/\/doi.org\/10.4049\/jimmunol.178.4.2287","journal-title":"J Immunol"},{"issue":"8","key":"6794_CR58","doi-asserted-by":"publisher","first-page":"5082","DOI":"10.4049\/jimmunol.179.8.5082","volume":"179","author":"E Tili","year":"2007","unstructured":"Tili E, Michaille JJ, Cimino A et al (2007) Modulation of miR-155 and miR-125b levels following lipopolysaccharide\/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 179(8):5082\u20135089. https:\/\/doi.org\/10.4049\/jimmunol.179.8.5082","journal-title":"J Immunol"},{"key":"6794_CR59","doi-asserted-by":"publisher","first-page":"12970","DOI":"10.1038\/ncomms12970","volume":"7","author":"S Alivernini","year":"2016","unstructured":"Alivernini S, Kurowska-Stolarska M, Tolusso B et al (2016) MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis. Nat Commun 7:12970. https:\/\/doi.org\/10.1038\/ncomms12970","journal-title":"Nat Commun"},{"issue":"1","key":"6794_CR60","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1182\/blood-2013-07-515254","volume":"123","author":"D Jiang","year":"2014","unstructured":"Jiang D, Aguiar RC (2014) MicroRNA-155 controls RB phosphorylation in normal and malignant B lymphocytes via the noncanonical TGF-beta1\/SMAD5 signaling module. Blood 123(1):86\u201393. https:\/\/doi.org\/10.1182\/blood-2013-07-515254","journal-title":"Blood"},{"key":"6794_CR61","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1146\/annurev.immunol.21.120601.141110","volume":"21","author":"RH Schwartz","year":"2003","unstructured":"Schwartz RH (2003) T cell anergy. Annu Rev Immunol 21:305\u2013334. https:\/\/doi.org\/10.1146\/annurev.immunol.21.120601.141110","journal-title":"Annu Rev Immunol"},{"key":"6794_CR62","doi-asserted-by":"publisher","first-page":"926648","DOI":"10.3389\/fimmu.2022.926648","volume":"13","author":"M Iglesias","year":"2022","unstructured":"Iglesias M, Brennan DC, Larsen CP, Raimondi G (2022) Targeting inflammation and immune activation to improve CTLA4-Ig-based modulation of transplant rejection. Front Immunol 13:926648. https:\/\/doi.org\/10.3389\/fimmu.2022.926648","journal-title":"Front Immunol"},{"issue":"5","key":"6794_CR63","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.4049\/jimmunol.166.5.2913","volume":"166","author":"DI Daikh","year":"2001","unstructured":"Daikh DI, Wofsy D (2001) Cutting edge: reversal of murine lupus nephritis with CTLA4Ig and cyclophosphamide. J Immunol 166(5):2913\u20132916. https:\/\/doi.org\/10.4049\/jimmunol.166.5.2913","journal-title":"J Immunol"},{"issue":"4","key":"6794_CR64","doi-asserted-by":"publisher","first-page":"e0153200","DOI":"10.1371\/journal.pone.0153200","volume":"11","author":"JS Shah","year":"2016","unstructured":"Shah JS, Soon PS, Marsh DJ (2016) Comparison of methodologies to detect low levels of hemolysis in serum for accurate assessment of serum microRNAs. PLoS One 11(4):e0153200. https:\/\/doi.org\/10.1371\/journal.pone.0153200","journal-title":"PLoS One"},{"issue":"10","key":"6794_CR65","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1038\/s41590-020-0744-z","volume":"21","author":"NM Edner","year":"2020","unstructured":"Edner NM, Heuts F, Thomas N et al (2020) Follicular helper T cell profiles predict response to costimulation blockade in type 1 diabetes. Nat Immunol 21(10):1244\u20131255. https:\/\/doi.org\/10.1038\/s41590-020-0744-z","journal-title":"Nat Immunol"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-026-06794-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-026-06794-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-026-06794-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:16:25Z","timestamp":1788441385000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-026-06794-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":65,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["6794"],"URL":"https:\/\/doi.org\/10.1007\/s00125-026-06794-3","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"14 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors thank the individuals who participated in this study, as well as the physicians, nurses and staff of the Children\u2019s Wisconsin and the Max McGee Research Center for Juvenile Diabetes who assisted in participant recruitment and sample collection\/processing. The authors thankfully acknowledge the philanthropy of the George and Ruth Leef Family and ITU AbsorbTech, Shirley and Albert Schmidt, the David & Julia Uihlein Charitable Foundation and the Children\u2019s Wisconsin Foundation.","order":1,"name":"Ethics","label":"Acknowledgements","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All microarray gene expression data files have been deposited at The National Center for Biotechnology Information Gene Expression Omnibus (accession no. GSE302205).","order":2,"name":"Ethics","label":"Data availability","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This work was supported by the American Diabetes Association (1-19-ICTS-129), National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK 125014 and R01 DK 121528), and Juvenile Diabetes Research Foundation International (3-SRA-2018-478-S-B). The studied clinical trials were performed under the auspices of the Type 1 Diabetes TrialNet Study Group, a clinical trials network funded by the NIH through the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Allergy and Infectious Diseases and the Eunice Kennedy Shriver National Institute of Child Health and Human Development via cooperative agreements U01 DK061010, U01 DK061016, U01 DK061034, U01 DK061036, U01 DK061040, U01 DK061041, U01 DK061042, U01 DK061055, U01 DK061058, U01 DK084565, U01 DK085453, U01 DK085461, U01 DK085463, U01 DK085466, U01 DK085499, U01 DK085505 and U01 DK085509, U01 DK085476, U01 DK097835, U01 DK103266, U01 DK103282, U01 DK 106984, U01 DK107014, U01 DK106993 and contract HHSN267200800019C. The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.","order":3,"name":"Ethics","label":"Funding","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.","order":4,"name":"Ethics","label":"Authors\u2019 relationships and activities","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"AB, C-WL, Y-GC and MJH conceived this project. TP, MFR and NAT conducted experiments. AB, SJ, C-WL and MJH analysed and\/or interpreted data. AB and MJH wrote the manuscript. All authors reviewed and edited the manuscript, and approved the final version. AB and MJH are the guarantors of the work.","order":5,"name":"Ethics","label":"Contribution statement","group":{"name":"EthicsHeading","label":"Ethics"}}]}}